Skip to content

   Pharma Publications

Neuropsychopharmacology
  • Identifying behavioral and biological predictors of cannabis vapor self-administration in rats
    Published on 2025-11-13
    9 months ago
  • Psychedelics produce enduring behavioral effects and functional plasticity through mechanisms independent of structural plasticity
    Published on 2025-11-12
    9 months ago
  • Independent brain cortical signatures of risk for adolescent cannabis use and consequences of such use are moderated by sex
    Published on 2025-11-12
    9 months ago
  • BDNF in ventrolateral orbitofrontal cortex to dorsolateral striatum circuit moderates alcohol consumption, seeking and relapse
    Published on 2025-11-08
    9 months ago
  • Associations of neuromelanin in the substantia nigra with antipsychotic response in schizophrenia
    Published on 2025-11-06
    9 months ago
  • Single-cell RNA sequencing uncovers molecular features underlying microglial lipid accumulation and depression-related behaviors in high-fat diet mouse model of obesity
    Published on 2025-11-05
    9 months ago
  • Pre-trauma cognitive traits predict fear generalization and associated prefrontal functioning in a longitudinal rodent model
    Published on 2025-11-03
    9 months ago
« Previous 1 … 32 33 34 35 36 … 143 Next »
Journal of Psychopharmacology
  • Repeated administration of L-alanine to mice reduces behavioural despair and increases hippocampal mammalian target of rapamycin signalling: Analysis of gender and metabolic effects
    Published on 2025-04-17
    1 year ago
  • Behavioral effects of three synthetic tryptamine derivatives in rodents
    Published on 2025-04-04
    1 year ago
  • Cannabimimetic and discriminative stimulus effects of hexahydrocannabinols in mice
    Published on 2025-04-03
    1 year ago
  • The Afterglow Inventory (AGI): Validation of a new instrument for measuring subacute effects of classic serotonergic psychedelics
    Published on 2025-04-01
    1 year ago
  • The anti-inflammation pharmacodynamics of lithium: Therapy of bipolar disorder
    Published on 2025-03-26
    1 year ago
  • Evaluating the efficacy of metformin in reducing hyperprolactinemia among patients with schizophrenia: A meta-analysis of randomized controlled trials
    Published on 2025-03-25
    1 year ago
  • Monoamine neurotransmitter-related gene-based genome-wide association study of low-dose ketamine in patients with treatment-resistant depression
    Published on 2025-03-25
    1 year ago
« Previous 1 … 32 33 34 35 36 … 150 Next »
European Neuropsychopharmacology
  • Low dose oral ketamine treatment on post-traumatic stress disorder (PTSD) (OKTOP): An open-label pilot study
    Published on 2025-02-05
    1 year ago
  • Preliminary evidence should be treated as such: Response to “Is creatine useful as adjuvant in cognitive-behavioural therapy for depression?”
    Published on 2025-02-05
    1 year ago
  • A specific GPR56/ADGRG1 splicing isoform is associated with antidepressant response in major depressive disorder
    Published on 2025-02-05
    1 year ago
  • Classical psychedelics in therapy: Essential psychotherapy or minimal support?
    Published on 2025-02-05
    1 year ago
  • Differential effects of Xanomeline-trospium chloride on positive and negative symptoms in Schizophrenia: The role of dose
    Published on 2025-02-05
    1 year ago
  • 3D imaging and geometric morphometrics of facial dysmorphology and asymmetry indicate gestational timings of dysmorphogenesis in schizophrenia and bipolar disorder
    Published on 2025-01-03
    2 years ago
  • MiRNAs and extracellular vesicles in psychiatry: Potential biomarkers, therapeutic advances, and animal models
    Published on 2025-01-03
    2 years ago
« Previous 1 … 32 33 34 35 36 … 168 Next »

   Pharma Pub